A Study to Evaluate Efficacy and Safety of CS-3150 in Japanese Hypertensive Subjects
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This study is a randomized, placebo-controlled, double-blind, multi-center study to evaluate
efficacy and safety of different doses of CS-3150 compared to placebo in Japanese
hypertensive subjects. Primary endpoint is change from baseline in sitting systolic and
diastolic blood pressure.